 |
|
Fat rat enables studies of debilitating vascular disease
October 10, 2005A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
"Everybody knows that obesity eventually causes diabetes and that when you have complications of the disease, you may even die," says Dr. David W. Stepp, cardiovascular researcher in the Medical College of Georgia Vascular Biology Center.
"What is underappreciated is that there are vascular changes and cardiovascular effects of obesity well before you become diabetic."
The Obese Zucker rat model shares the symptoms of obesity with a growing number of Americans. "For example, these animals are glucose intolerent, slightly hypertensive and showing protein in their urine. They have kidney dysfunction even though they are not yet diabetic," he says.
That is because small blood vessels in their kidneys already have begun to fail. All the fat rats eventually will get diabetes, but these ailing animals still have the same blood glucose levels as their lean peers. "When they go into frank diabetes, that pushes their kidneys over the edge. The goal of our lab is to use this model to examine vascular disease in other organs, especially the limbs."
Dr. Stepp recently received a $1.4 million grant from the National Heart, Lung and Blood Institute to study these early vascular changes, called peripheral vascular disease, that can result from obesity, smoking and inactivity.
His goal is to prevent a common condition with significant quality-of-life consequences. "The reason peripheral vascular disease is of interest to us is not because it kills but because patients with it often have quality of life indices worse than those of terminal cancer," Dr. Stepp says. "They can't walk. They don't have any mobility. They are not free. They feel humiliated and miserable."
Causes are multifaceted. "One of the things that goes on is the number of vessels shrinks," says Dr. Stepp, leaving legs, for example, starved for blood and oxygen. "What we think happens is the sympathethic nervous system, which makes blood pressure go up, is cranked up in obese individuals."
To make matters worse, obesity also changes energy use in the body, creating a state called insulin-resistance, a precursor for diabetes, that in the shorter term dumps more fat, or lipid, in the blood. Changed blood content affects sensitive blood vessel lining so vessels don't dilate well. That increased pressure decreases blood flow which gives surrounding tissue the wrong idea. "The dilator signal is not getting through, the constrictor signal is too high so blood pressure goes up and blood flow goes down," says Dr. Stepp. "If your blood flow is chronically low, your local organs say, 'Oh the flow is low. I must not need this vessel,' and it goes away. Anything you don't use atrophies."
Interestingly, lost vessels may not be missed until the person tries to be more active and the deprived tissue protests with pain.
"As long as you don't do that much, low blood flow is fine; you can function," says Dr. Stepp. "But now let's say you have a clot in one of your arteries and you need to increase blood flow to get around it. You can't do it. Now let's say you want to exercise. You can't do it. All the blood supply, all the reserve you think you are supposed to have, is gone."
He sees this in his Zucker rats. Lean rats love to run fast but the fat rats have dramatically reduced capacity for such sport.
"One of the things we would like to find out is, if we train the animals, can we get that capacity back? That we don't know. Nobody has done that."
Another key question is how much the revved-up sympathetic nervous system, reduced ability to dilate and structural changes in blood vessel linings each contribute to peripheral vascular disease. And, if you take one away, say with vasodilators to improve dilatation, does it fix the problem?
"One of the questions we are asking is how much of vascular disease is metabolic changes and how much is just from being obese? They go hand-in-hand, but which one is causing the disease? What if you subtract one of them out? Will you get it slower, or not at all or some mixed portion of it? If we can identify the root cause of the end-stage disease, we can design therapies to intervene early and develop better diagnostic tools," Dr. Stepp says.
So he looks at what happens to exercise capacity when the sympathetic nervous system is blocked or a nitrate patch is used to improve impaired dilation.
"The holy grail of all this is if you can figure out how obesity impairs vascular fucntion and how exercise makes it better and bottle it," he says, acknowledging obvious questions about why obese people can't just exercise. "While it's easy to say 'go exercise,' people who are genetically obese (about 50 percent of the obese population) or who have been obese all their lives may have trouble exercising intensely enough to improve vascular function. By indentifying ways to mimic the positive effects of exercise in an obese population, we may come up with new ways to treat all patients who have peripheral vascular disease."
Medical College of Georgia
The Obese Zucker rat model shares the symptoms of obesity with a growing number of Americans. "For example, these animals are glucose intolerent, slightly hypertensive and showing protein in their urine. They have kidney dysfunction even though they are not yet diabetic," he says.
That is because small blood vessels in their kidneys already have begun to fail. All the fat rats eventually will get diabetes, but these ailing animals still have the same blood glucose levels as their lean peers. "When they go into frank diabetes, that pushes their kidneys over the edge. The goal of our lab is to use this model to examine vascular disease in other organs, especially the limbs."
Dr. Stepp recently received a $1.4 million grant from the National Heart, Lung and Blood Institute to study these early vascular changes, called peripheral vascular disease, that can result from obesity, smoking and inactivity.
His goal is to prevent a common condition with significant quality-of-life consequences. "The reason peripheral vascular disease is of interest to us is not because it kills but because patients with it often have quality of life indices worse than those of terminal cancer," Dr. Stepp says. "They can't walk. They don't have any mobility. They are not free. They feel humiliated and miserable."
Causes are multifaceted. "One of the things that goes on is the number of vessels shrinks," says Dr. Stepp, leaving legs, for example, starved for blood and oxygen. "What we think happens is the sympathethic nervous system, which makes blood pressure go up, is cranked up in obese individuals."
To make matters worse, obesity also changes energy use in the body, creating a state called insulin-resistance, a precursor for diabetes, that in the shorter term dumps more fat, or lipid, in the blood. Changed blood content affects sensitive blood vessel lining so vessels don't dilate well. That increased pressure decreases blood flow which gives surrounding tissue the wrong idea. "The dilator signal is not getting through, the constrictor signal is too high so blood pressure goes up and blood flow goes down," says Dr. Stepp. "If your blood flow is chronically low, your local organs say, 'Oh the flow is low. I must not need this vessel,' and it goes away. Anything you don't use atrophies."
Interestingly, lost vessels may not be missed until the person tries to be more active and the deprived tissue protests with pain.
"As long as you don't do that much, low blood flow is fine; you can function," says Dr. Stepp. "But now let's say you have a clot in one of your arteries and you need to increase blood flow to get around it. You can't do it. Now let's say you want to exercise. You can't do it. All the blood supply, all the reserve you think you are supposed to have, is gone."
He sees this in his Zucker rats. Lean rats love to run fast but the fat rats have dramatically reduced capacity for such sport.
"One of the things we would like to find out is, if we train the animals, can we get that capacity back? That we don't know. Nobody has done that."
Another key question is how much the revved-up sympathetic nervous system, reduced ability to dilate and structural changes in blood vessel linings each contribute to peripheral vascular disease. And, if you take one away, say with vasodilators to improve dilatation, does it fix the problem?
"One of the questions we are asking is how much of vascular disease is metabolic changes and how much is just from being obese? They go hand-in-hand, but which one is causing the disease? What if you subtract one of them out? Will you get it slower, or not at all or some mixed portion of it? If we can identify the root cause of the end-stage disease, we can design therapies to intervene early and develop better diagnostic tools," Dr. Stepp says.
So he looks at what happens to exercise capacity when the sympathetic nervous system is blocked or a nitrate patch is used to improve impaired dilation.
"The holy grail of all this is if you can figure out how obesity impairs vascular fucntion and how exercise makes it better and bottle it," he says, acknowledging obvious questions about why obese people can't just exercise. "While it's easy to say 'go exercise,' people who are genetically obese (about 50 percent of the obese population) or who have been obese all their lives may have trouble exercising intensely enough to improve vascular function. By indentifying ways to mimic the positive effects of exercise in an obese population, we may come up with new ways to treat all patients who have peripheral vascular disease."
Medical College of Georgia
Vascular Disease Current Events and Vascular Disease News RSSAdding ezetimibe to atorvastatin improves lipid control
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone.
Obesity may hinder optimal control of blood pressure and cholesterol
Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD).
Radiologists find a technique to significantly reduce patient radiation dose during CT angiography
Radiologists have discovered that prospective electrocardiogram (ECG) gating allows them to significantly reduce the patient radiation dose delivered during computed tomography (CT) angiography, a common noninvasive technique used to evaluate vascular disease.
Many Australians at risk of cardiovascular disease are not receiving best practice care
Many people are not receiving the best possible care when it comes to managing cardiovascular conditions according to two new Australian research studies.
Link between depression, early stages of chronic kidney disease found by researchers
One in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease, UT Southwestern Medical Center researchers have found.
Team reveals molecular mechanism underlying a form of diabetes
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion.
Surprising rate of recurring heart attacks, strokes globally
Despite many medicines and other treatments for patients with vascular disease, a large international study shows these patients have a surprisingly high rate of recurring events such as strokes, heart attacks and hospitalizations as well as mortality.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
More Vascular Disease Current Events and Vascular Disease News Articles
 |
Handbook of Patient Care in Vascular Diseases (Lippincott Williams & Wilkins Handbook) by Todd E Rasmussen (Author), W. Darrin Clouse (Author), Britt H Tonnessen (Author) Completely revised by a team of new authors with expertise in endovascular procedures, this handbook is a quick reference for the effective treatment of patients with common arterial and venous diseases. In concise outline format, the book covers all major vascular disorders, including peripheral vascular diseases, and emphasizes patient management issues rather than step-by-step surgical procedures. This Fifth Edition covers common endovascular procedures and their preoperative and postoperative management issues. A major section provides disease-specific care outlines for various vascular disease categories, with references to the contemporary literature. From diagnosis to follow-up, each chapter includes indications for therapy, periprocedural management, and valuable tips on avoiding... |
|
South African Journal of Diabetes and Vascular Disease by Clinics Cardive Publishing Co | |
 |
FlameEz-Vascular, 60 Capsules/Bottle by FlameEz Inflammation plays a key role in plaque building up in coronary arteries, which leads to heart disease and heart attack. At the early stage, the plaque can build up quickly in inflamed arteries. If inflammatory conditions persist, the plaque can expand rapidly causing blood vessel narrowing. In advanced stage, inflammation leads to development of "soft" plaque that can rupture suddenly and cause heart attack. For many, cardiovascular disease is a silent disease, with no visible signs or symptoms until it suddenly leads to a heart attack or stroke. It is widely accepted that control of inflammation may yield a more ‘stable’ plaque that less likely to rupture. However, there are currently no medications available for direct treatment of the underlying chronic inflammation associated... |
 |
Vascular Medicine - A Companion to Braunwald's Heart Disease Expert Consult Online and Print by Mark A. Creager (Author), Victor J. Dzau (Author), Joseph Loscalzo (Author) Tap into the latest knowledge and approaches to vascular medicine with the comprehensive, clinically oriented coverage of this new addition to the Braunwald’s Heart Disease family. You’ll find today’s best methods for identifying and treating arterial diseases of the limbs * renal, mesenteric and cerebral circulation problems * aortic aneurysms * vasospastic diseases * vasculitides * venous thromboembolisms * lymphedema * and much more. * Integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular disease. * Covers the fundamental biology of blood vessels and the pathobiologic foundation of vascular disease. * Provides an in-depth, state-of-the-art review of all vascular diseases with emphasis on pathophysiology, diagnosis, and management.... |
 |
Cognitive Aging and Alzheimer's Disease: Gender Matters What is normal versus abnormal cognitive function in women, versus men, and how does dementia make itself known? What can be done to prevent Alzheimer's Disease? |
|
Diagnostic and Therapeutic Approaches to Vascular Disease [VHS] Starring: University of Washington School of Medicine | |
 |
Retinal Vascular Disease by A.M. Joussen (Editor), T.W. Gardner (Editor), B. Kirchhof (Editor), S.J. Ryan (Editor) Vascular diseases of the retina are a major cause of blindness among all age groups. Edited and written by internationally well-known experts, this state-of-the-art comprehensive overview of basic and clinical science will enhance the understanding of retinal vascular disease and help in the evaluation of current and future treatment approaches for the clinician. The well-structured and highly illustrated text is divided into the following three main sections: |
|
Vascular Disease Management by Hmp Communications | |
 |
Manual Of Vascular Diseases by Lippincott Williams & Wilkins Manual of Vascular Diseases : Manual of Vascular Diseases Pub Date: August 2004 Product Type: Print Author/s: Sanjay Rajagopalan MD; Debabrata Mukherjee MD, MS, FACC; Emile R Mohler III, MD This convenient and portable manual written by cross-disciplinary leading experts is a practical /"how-to/" guide which emphasizes management of vascular diseases. Designed for quick reference at the point of care, the manual provides easy access to information that is crucial for clinical decision making.Chapters succinctly describe the most effective diagnostic assessment and treatment strategies, including drug doses, protocols for patient management, and algorithms. The book also includes chapters on diagnostic aspects of lower extremity arterial disease, history and physical... |
 |
Mechanisms of Vascular Disease: A Textbook for Vascular Surgeons by Robert Fitridge (Editor), Matthew Thompson (Editor) This textbook provides an up-to-date account of the mechanisms and pathophysiology of vascular disease, and the current treatment options open to vascular surgeons. As the scientific basis of vascular disease advances rapidly, it is critical that clinicians have access to relevant information written specifically for vascular surgeons. This account reviews the impact of these scientific advances on established and emerging treatment options. Experts from Australia, North America and Europe have contributed to basic topics such as atherosclerosis, restenosis, thrombosis and hemostasis, ischaemia-reperfusion injury, sepsis, vascular hemodynamics and wound healing. More applied topics such as pain syndromes in vascular surgery and the diabetic foot are also covered in this textbook. This... |
| © 2009 BrightSurf.com |